Clinical trials: TKA Outcomes

Arthroplasty, Arthroplasty Replacement, Knee

oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study

• Not yet recruiting
• Age: 18 to 79 years
• Observational study
• Medical device

Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.

Conditions

Arthroplasty, Arthroplasty Replacement, Knee, Prosthetic Joint Infections of Knee, TKA Outcomes

Trial name

oneKNEE (NCT07682909)

Testing

oneKNEE®

Volunteers

1,020 people

Sponsor

Aesculap AG